Let us explore the patient guide to US FDA-approved CAR T therapies, dosage, safety concerns and risk management (REMS), efficacy in clinical trials, and impact. CAR T cell therapy is approved by the US FDA to treat defined conditions of leukemia, lymphoma, and multiple myeloma. It is often used as a last resort, after one … Continue reading A Patient’s Guide to CAR-T Therapy: Unleashing the Power Within